ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr. Director, ADC Drug-Linker Synthetic Process Development at Eli Lilly and Company - ApplyBlast

Sr. Director, ADC Drug-Linker Synthetic Process Development

Eli Lilly and Company

10 months ago

4.0 on Glassdoor

United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Senior Director role within Eli Lilly’s Bioproduct Research & Development organization leading payload-linker development at the small-molecule–biologics interface for antibody-drug conjugates (ADCs). The position focuses on driving design, optimization, and scale-up of linker and payload synthetic chemistry to enable commercialization of next-generation ADC therapeutics. The role partners closely with discovery, CMC, and manufacturing stakeholders and supports growth of internal capabilities and team development.

Skills

Qualifications

Ph.D. in Synthetic Organic ChemistryM.S. in Relevant Discipline (or B.S. with 15+ Years Equivalent Experience)B.S. in Relevant Discipline (15+ Years Equivalent Experience)

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.